In the current study, we did not observe similar involvement of STAT3 in oral cancer (Fig. S8), suggesting that cell type differences between oral cancer (squamous cell carcinoma) and breast cancer (adenocarcinoma) may contribute to differences in the MRE11-preferential signaling pathways. The gene discussed is STAT3; the disease is lip and oral cavity carcinoma.